The Swiss Biotech Association and swissnex San Francisco invite interested parties to a networking event during “Biotech Week.” If you are a biotech company, investor, start-up, spin-off, part of the swissnex or SBA communities, or an academic-industry liaison, this might be for you.
The Swiss Biotech Association (SBA) represents more than 200 small and medium-sized enterprises active in all areas of biotechnology, a robust Swiss industry. Join representatives from this sector to discuss new ways of financing biotech ventures, a necessary step in sustaining and expanding the biotech business.
Program
|
6:00 pm |
opening and welcome by Domenico Alexakis, Swiss Biotech Association and Christian Simm, swissnex San Francisco |
|
6:15 pm |
A next generation business model targeting the important orphan drug market – Frank Grossmann, CEO, orphanbiotec AG |
|
6:30 pm |
An open-source bioscience technology company delivering a pipeline for Rare Diseases – Paolo Bassanini, Investor & External Relations, mondoBIOTECH |
|
6:45 pm |
A start-up company targeting cancer-initiating cells, the roots of cancer – Daniel Leutenegger, CEO & Co-Founder, Stemergie Biotechnology SA |
|
7:00 pm |
Alternative Strategies to Finance Drug Development – Roundtable discussion moderated by Alexander Fries, President, Ecosystem Ventures LLC |
|
7:30 pm |
networking reception |
Photo: Myleen Hollero
